Lucid Diagnostics (LUCD) Share-based Compensation (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Lucid Diagnostics | 145.00 Mn | 117.12 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.63% |
| Dec 31, 2025 | 9.72% |
| Sep 30, 2025 | 0.79% |
| Jun 30, 2025 | 10.97% |
| Mar 31, 2025 | -12.04% |
| Dec 31, 2024 | -4.64% |
| Sep 30, 2024 | 2.25% |
| Jun 30, 2024 | 28.72% |
| Mar 31, 2024 | 1,061.86% |
| Dec 31, 2023 | -107.75% |
| Sep 30, 2023 | -10.51% |
| Jun 30, 2023 | -50.34% |
| Mar 31, 2023 | -19.24% |
| Dec 31, 2022 | -2.32% |
| Sep 30, 2022 | -7.10% |
| Jun 30, 2022 | 0.23% |
| Mar 31, 2022 | 11.39% |
| Dec 31, 2021 | 24.21% |
| Sep 30, 2021 | 7.44% |
| Jun 30, 2021 | 220.50% |
| Mar 31, 2021 | 4,960.98% |
| Dec 31, 2020 | -2.80% |